glp-1 depression A recent post hoc analysis published in Obesity found tirzepatide vs. placebo was not associated with increased risk of symptoms. Rates of suicidal ideation and behavior were low and similar to UF researchers demonstrate GLP-1RAs' potential

Lets take a closer look at what makes it such a game-changer

The strongest published finding is from the foundational Biochemical Pharmacology study by Neelakantan et al.: in diet-induced obese mice, daily 5-Amino-1MQ administration produced reductions in body weight, white adipose tissue mass, and adipocyte size without any significant change in food intake

Read clinical review Clinical Reviews GIP/GLP-1 Dual Agonists: Class Overview Monograph A prescriber-level monograph covering the pharmacology, clinical trial data, dosing, safety, and approved indications for GIP/GLP-1 dual agonists, with tirzepatide as the class prototype

As natural collagen production gradually slows, your skin may lose firmness and elasticity

Gather safety data by reporting adverse events, including any miscarriages or birth defects

Thyroid Antibodies Test Test TPO and TG antibodies markers relevant to autoimmune thyroid conditions such as Hashimoto's or Graves'